ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 06:30:00 28/08/26 am AEST			5-day change	1st Jan Change
1.665 ^USD	-0.30%		+2.15%	-8.52%

20/08	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI
18/08	Alzamend Neuro, Inc. Reports Phase 1/2A Lithium Imaging Data For AL001 At ISMRM Workshop	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

10c69cc.pnFTYeWsaT7_Tay7e26BTmWEmr7CPvztyFMdybL2YCw.8zY6K9GZP1y4fvaPJAyydyHQwvCjaNGogz55he2DDEbJMx1Tiu5ECLE_7Q~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

12/04/23	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
28/12/21	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
02/10/21	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,461.56%
	LONZA GROUP AG					+15.76%
	REVOLUTION MEDICINES, INC.					+9.73%
	IQVIA HOLDINGS INC.					+4.87%
	BEONE MEDICINES AG					+16.02%
	CELLTRION, INC.					+39.07%
	MEDPACE HOLDINGS, INC.					-4.86%
	ASCENDIS PHARMA A/S					+26.83%
	EUROFINS SCIENTIFIC SE					-0.65%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					-5.2%
	Average					+156.31%
	Weighted average by Cap.					+13.37%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.665USD

Average target price

26.00USD

Spread / Average Target

+1,461.56%

High Price Target

26.00USD

Spread / Highest target

+1,461.56%

Low Price Target

26.00USD

Spread / Lowest Target

+1,461.56%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

As early as today, start finding the best investment opportunities!